- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01604538
Italian Pulmonary Embolism Registry - IPER (IPER)
Italian Pulmonary Embolism Registry
RAZIONALE
Pulmonary embolism is a complex disease, with a highly variable clincal presentation. Diagnosis starts with clinical probability assessment mainly based on medical history and rapidly available clinical data. Pulmonary embolism can be managed by emergency department, cardiology, pneumology geriatrics or internal medicine physicians. Thus, initial clinical management can varies based on the attitude of the attending physician.
Diagnosis is a crucial point as it can influence short term mortality.
OBJECTIVE
The registry has 3 main objectives:
- educational objective,
- improvement in the knowledge of epidemiology, management and outcome of acute pulmonary embolism in Italy
- scientific objective
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- consecutive patients with acute pulmonary embolism
Exclusion Criteria:
- age <18 years
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
patients with acute pulmonary embolism
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Franco Casazza, MD, San Carlo Borromeo hospital, Milan, Italy
Publications and helpful links
General Publications
- Zuin M, Bilato C, Bongarzoni A, Zonzin P, Casazza F, Rigatelli G, Roncon L. Impact of clinical profile at admission on the outcomes in patients hospitalized for acute pulmonary embolism: data from the IPER Registry. J Thromb Thrombolysis. 2022 Nov 9. doi: 10.1007/s11239-022-02726-1. Online ahead of print.
- Becattini C, Casazza F, Forgione C, Porro F, Fadin BM, Stucchi A, Lignani A, Conte L, Imperadore F, Bongarzoni A, Agnelli G. Acute pulmonary embolism: external validation of an integrated risk stratification model. Chest. 2013 Nov;144(5):1539-1545. doi: 10.1378/chest.12-2938.
Study record dates
Study Major Dates
Study Start
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- protocol_364
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Pulmonary Embolism
-
Hospital San Carlos, MadridAsociación de Cardiología Intervencionista de la Sociedad Española de CardiologíaRecruitingPulmonary Embolism | Pulmonary Embolism and Thrombosis | Pulmonary Thromboembolisms | Pulmonary Embolism Acute | Pulmonary Embolism Acute MassiveSpain
-
Inari MedicalCompletedPulmonary Embolism | Submassive Pulmonary Embolism | Acute Pulmonary Embolism | Massive Pulmonary EmbolismUnited States
-
Boston Scientific CorporationEKOS CorporationCompletedPulmonary Embolism | Acute Pulmonary Embolism | Pulmonary Thromboembolism | Massive Pulmonary Embolism | Sub-massive Pulmonary EmbolismUnited States
-
University of California, Los AngelesEnrolling by invitationPulmonary Disease | Pulmonary Embolism | Pulmonary Embolus/Emboli | Pulmonary Embolism and Thrombosis | Pulmonary Embolism Subacute Massive | Pulmonary Embolism Acute MassiveUnited States
-
Imperative Care, Inc.RecruitingCardiovascular Diseases | Vascular Diseases | Embolism | Thrombosis | Thromboembolism | Acute Pulmonary Embolism | Thrombus; Embolism | Emboli, PulmonaryUnited States
-
Medical University of WarsawRecruiting
-
Medical University of WarsawCompletedAcute Pulmonary EmbolismPoland
-
Tasly Biopharmaceuticals Co., Ltd.CompletedAcute Pulmonary EmbolismChina
-
Angde Biotech Pharmaceutical Co., Ltd.Unknown
-
Agen BiomedicalCompletedAcute Pulmonary EmbolismUnited States, Canada